Deregulated Aiolos expression in common variable immunodeficiency

Open Immunology Journal

Volumn 2, Issue 1, 2009, Pages 52-58

  Billot, Katy ^a   Arrouss, Issam ^a   Garcia Alvarez, Gisela ^b   Oksenhendler, Eric ^c,d   Mouillot, Gael ^a   Debre, Patrice ^a   Rebollo, Angelita ^a,b  

^a Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d DEFI Study Group

Author keywords

Aiolos; Common variable immunodeficiency; Transcription factor

Indexed keywords

AIOLOS TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; B LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DEREGULATION; FEMALE; HUMAN; MALE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION;

EID: 77953453950     PISSN: None     EISSN: 18742262     Source Type: Journal    
DOI: 10.2174/1874226200902010052     Document Type: Article

References (20)

1. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.
2. Agematsu K, Futatani T, Hokibara S et al. Absence of memory B cells in patients with common variable immunodeficiency. Clin Immunol 2002; 103: 34-42.
3. Bayry J, Hermine O, Webster DA, Levy Y, Kaveri SV. Common variable immunodeficiency: the immune system in chaos. Trends Mol Med 2005; 11: 370-376
4. Brouet JC, Chedeville A, Fermand JP, Royer B. Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol 2000; 30: 2516-2520
5. Wang JH, Avitahl N, Cariappa A et al. Aiolos regulates B cell activation and maturation to effector state. Immunity 1998; 9: 543-553
6. Wang JH, Nichogiannopoulou A, Wu L et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996; 5: 537-549
7. Ghadiri A, Duhamel M, Fleischer A, Reimann A, Dessauge F, Rebollo A. Critical function of Ikaros in controlling Aiolos gene expression. FEBS Lett 2007; 581: 1605-1616
8. Ayllon V, Fleischer A, Cayla X, Garcia A, Rebollo A. Segregation of Bad from lipid rafts is implicated in the induction of apoptosis. J Immunol 2002; 168: 3387-3393
9. Romero F, Martinez AC, Camonis J, Rebollo A. Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization. EMBO J 1999; 18: 3419-3430
10. Liippo J, Nera KP, Veistinen E et al. Both normal and leukemic B lymphocytes express multiple isoforms of the human Aiolos gene. Eur J Immunol 2001; 31: 3469-3474
11. Duhamel M, Arrouss I, Merle-Beral H, Rebollo A. The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia. Blood 2008; 111: 3225-3228
12. Nakase K, Ishimaru F, Fujii K et al. Overexpression of novel short isoforms of Helios in a patient with T-cell acute lymphoblastic leukemia. Exp Hematol 2002; 30: 313-317
13. Caballero R, Setien F, Lopez-Serra L et al. Combinatorial effects of splice variants modulate function of Aiolos. J Cell Sci 2007; 120: 2619-2630
14. Narvi E, Nera KP, Terho P, Mustonen L, Granberg J, Lassila O. Aiolos controls gene conversion and cell death in DT40 B cells. Scand J Immunol 2007; 65: 503-513
15. Boise LH, Gottschalk AR, Quintans J, Thompson CB. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr Top Microbiol Immunol 1995; 200: 107-121
16. Di Renzo M, Zhou Z, George I, Becker K, Cunningham-Rundles C. Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co-stimulation. Clin Exp Immunol 2000; 120: 503-511
17. Ferrer A, Ollila J, Tobin G et al. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2004; 153: 69-72.
18. Pokholok DK, Harbison CT, Levine S et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 2005; 122: 517-527
19. Nera KP, Lassila O. Pax5--a critical inhibitor of plasma cell fate. Scand J Immunol 2006; 64: 190-199
20. Morra M, Silander O, Calpe S et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood 2001; 98: 1321-1325